#kidneycancer
A pleasure to Present our OncoAlert 🚨GU faculty Sumanta K. Pal, MD, FASCO 🇺🇸of City of Hope DISCUSSING: Adjuvant Therapy in Renal Cell Carcinoma #KidneyCancer directly from #IUCS25 Portsmouth 🇬🇧 International Urology Cancer Summit All abstracts from IUCS25 can be found at The Oncologist Chairs Giuseppe Banna and Ravindran Kanesvaran Sumanta K. Pal, MD, FASCO Yüksel Ürün Emre Yekedüz Bárbara Melão, MD, PhD Gil Morgan, MD Alison Tree 💙 Naveen Vasudev Prof Ananya💙 @achoud72.bsky.social THE DR. A.M.G (ARUNI GHOSE) Laura Marandino Emanuele Crupi Daniele Raggi Prof Param Mariappan FRCS(Urol), PhD Sara Elena Rebuzzi Vishwani Chauhan ONCOassist® | The go-to oncology app Prostate Cancer UK Enrique Grande Petros Grivas Laurence Albiges Dra. María Natalia Gandur Quiroga pas_rescigno Elena Castro John McGrane Simply Oncology Ricky Frazer The Immunobuddies Podcast
OncoAlert10,814 views • 9 months ago
LIVE from #GUTrends25 from Canary Islands🇪🇸 Our friends Uromigos ( Tom Powles & Brian Rini, MD ) Discuss Kidney Cancer Biomarkers (Brian's favourite Childhood memory). Join the Uromigos for a lively discussion beachfront🌴🌴 centering on the complexities of #KidneyCancer biomarkers. Tom presents a slide summarizing the state of tissue-based biomarkers in kidney cancer, focusing on trials comparing VEGF TKIs, IO combinations, and the Ipi-Nivo trial. While there is consistency in predicting response to VEGF TKIs, immune therapy biomarkers remain elusive. Brian and Tom discuss inconsistencies in RNA, DNA, and protein analysis across trials, the challenges of identifying reliable biomarkers, and C-MYC mutation's association with poor outcomes. They also touch on PDL1, arguing it is not a singular biomarker but a combination that varies in effect. Finally, attention shifts to KIM-1, a promising serum biomarker that might hold future potential for guiding treatment, with the group reflecting on the evolution of biomarker research and emphasizing the importance of learning from past trials to move the field forward. Ping: Dra. María Natalia Gandur Quiroga Bárbara Melão, MD, PhD Daniel Castellano Elena Castro Maite Bourlon ウロミーゴズ Guillermo de Velasco
OncoAlert13,860 views • 1 year ago
DAY ONE🚨 #GUARDSymposium2025 Presenting Roberto Iacovelli 🇮🇹 on How to Treat Patients in 2nd Line after progression to TKI+IO #KidneyCancer Tom Powles Syed A Hussain Matt Galsky Andrea Necchi Félix Guerrero-Ramos Mario AlvarezMaestro Urbano Anido Javier Molina Cerrillo David Lorente Vital Hevia Ana Plata bello Daniel Pérez Fentes Roberto Iacovelli Pedro C Barata, MD MSc FACP Abrahams Ocanto Mario Dominguez Esteban Alfonso Gómez de Liaño Cristina Rodriguez-Antona GUARD Consortium #ProstateCancer #BladderCancer #KidneyCancer Ping Daniel Castellano Enrique Grande Elena Castro Dra. María Natalia Gandur Quiroga Bárbara Melão, MD, PhD
OncoAlert10,486 views • 1 year ago
Welcome to GU Week🚨 from OncoAlert TODAY: The BEST of #KidneyCancer with Wenxin (Vincent) Xu 🇺🇸of Dana-Farber A Complete 1⃣5⃣minute Dive of the TOP trials in Kindey #cancer including those Trials that are Practice Changing‼️ Brought to you by OncoAlert European Society of Surgical Oncology (ESSO) MASCC ESGO and SIOG in collaboration with GUARD Consortium KidneyCAN & GU Cast | Urology podcast! Sumanta K. Pal, MD, FASCO Cristiane D Bergerot Daniel Heng Andrea Apolo, M.D. Toni Choueiri, MD Petros Grivas Tian Zhang, MD, MHS Hans Hammers Ravindran Kanesvaran Neeraj Agarwal, MD, FASCO Axel S. Merseburger Guru P. Sonpavde, MD Enrique Grande Simon C silke gillessen Tom Powles David Braun Daniel Castellano Sean McBride Yüksel Ürün MJosé Juan Elena Sevillano M.D. PhD #OncoAlertAF Dra. María Natalia Gandur Quiroga Alizée Camps - - Maléa Biagio Ricciuti, MD PhD Emre Yekedüz Hidehito HORINOUCHI Fadi Haddad, MD Al-Ola A Abdallah MD (USMIRC) Jose Fernando Moura, PhD Elisa Agostinetto Elisabetta Bonzano MD, PhD Bárbara Melão, MD, PhD Dr Joseph McCollom DO Erman Akkus Luca Arecco, MD Gaia Griguolo Kristina Jankovic, MD
OncoAlert11,729 views • 1 year ago
No more content to load